We are elated to share the success of the 11th International Annual Conference of the Fertility Preservation Society of India (FPSI), FertiProtect 2024, held recently with great enthusiasm and participation from doctors across the country. Dr. S. Vyjayanthi served as the Organising Chairperson for this prestigious event, which proved to be a remarkable platform for fostering learning and collaboration among some of the brightest minds in the field of fertility preservation.
A Unique Multidisciplinary Event
This year’s FertiProtect saw participation from close to 120 doctors specializing in various fields such as medical oncology, surgical oncology, pediatric hemato-oncology, rheumatology, andrology, fertility specialists, embryology, and gynecology. The event provided a unique opportunity for these professionals to share insights, discuss cutting-edge research, and collaborate on strategies to improve patient outcomes. This multidisciplinary focus has become a hallmark of FPSI’s commitment to a holistic approach in the field of fertility preservation.
Bringing Together Global Experts
The conference was honored by the presence of distinguished international experts whose contributions significantly enriched the proceedings:
- Prof. Anderson (Denmark): Known for his pioneering work in fertility preservation.
- Prof. Von Wolff (Switzerland): An esteemed figure in reproductive medicine.
- Dr. Sule Yildiz (Turkey): A leading expert in oncofertility.
These renowned specialists shared their knowledge and experiences, which sparked engaging discussions and provided invaluable learning opportunities for the attendees. Their presence further elevated the conference’s stature, making it a truly global event.
Celebrating the Success of FPSI
A heartfelt appreciation goes to Dr. Nalini Mahajan, the Founder President of FPSI, Dr. Madhuri Patil, the current President of FPSI, and Dr. Shobana Patted, Secretary General of FPSI, whose relentless efforts and visionary leadership played a pivotal role in making FertiProtect 2024 a grand success. Their support and guidance have been instrumental in driving FPSI’s mission of promoting fertility preservation, both nationally and internationally.
MotherToBe: Committed to Fertility Preservation
At MotherToBe, we are deeply committed to advancing the field of fertility preservation for young men, women, and children facing fertility-compromising treatments such as chemotherapy for cancer and bone marrow transplants (BMT) for hematological diseases. We offer a range of fertility preservation options, including:
- Egg Freezing
- Embryo Freezing
- Ovarian Tissue Cryopreservation
- Testicular Tissue Cryopreservation
While these techniques are still in their early stages of development, they offer a ray of hope for individuals at risk of losing their fertility due to medical treatments. Our team at MotherToBe is dedicated to making these technologies more accessible and effective, ensuring that patients have the best chance at parenthood in the future.
Looking Towards the Future
The discussions at FertiProtect 2024 emphasized the importance of continued collaboration among specialists to advance research and clinical practices in fertility preservation. As we look ahead, our focus remains on enhancing patient care, refining existing techniques, and exploring innovative approaches to meet the growing demand for fertility preservation services.
We are excited to continue our journey alongside our esteemed colleagues and partners in the field, contributing to the future of fertility care and making a positive impact on the lives of patients in need.
